Overview

Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

Status:
NOT_YET_RECRUITING

Trial end date:
2026-07-31

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy of Megestrol Acetate Oral Suspension in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy in Malignant Solid Tumor Patients

Phase:

PHASE1

Details

Lead Sponsor:

Changchun GeneScience Pharmaceutical Co., Ltd.

Treatments:

Standard of Care